↑ 薬物リストへ　← 戻る

Incb050465 hydrochloride    (DrugBank: INCB050465)

2 diseases
告示番号疾患名（ページ内リンク）臨床試験数
35天疱瘡1
61自己免疫性溶血性貧血0

35. 天疱瘡　［臨床試験数：87，薬物数：114（DrugBank：37），標的遺伝子数：17，標的パスウェイ数：158］
Searched query = "Pemphigus"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 87 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2018-002146-37-IT
(EUCTR)		20/03/201904/11/2020A study to test if increasing doses of the drug INCB050465 is safe and well tolerated in patients with Pemphigus VulgarisA Phase 2 Dose-Escalation Study of the Safety and Tolerability of INCB050465 in Participants With Pemphigus Vulgaris - NA Pemphigus vulgaris
MedDRA version: 20.0;Level: LLT;Classification code 10052802;Term: Pemphigus vulgaris;System Organ Class: 100000004858;Therapeutic area: Diseases [C] - Immune System Diseases [C20]		Trade Name: NA
Product Name: INCB050465 1.0 mg
Product Code: [NA]
INN or Proposed INN: INCB050465
Product Name: INCB050465 0.3 mg
Product Code: [NA]
INN or Proposed INN: INCB050465
Product Name: INCB050465 2.5mg
Product Code: [NA]
INN or Proposed INN: INCB050465 HYDROCHLORIDE		INCYTE CORPORATIONNULLNot RecruitingFemale: yes
Male: yes		18Phase 2France;Canada;Italy

61. 自己免疫性溶血性貧血　［臨床試験数：90，薬物数：72（DrugBank：23），標的遺伝子数：19，標的パスウェイ数：147］
Searched query = "Autoimmune hemolytic anemia", "AIHA", "WAIHA", "Cold agglutinin disease", "CAD", "Paroxysmal cold hemoglobinuria", "MAIHA", "Evans syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 90 trial found